CMS approval expected for Amyvid after FDA approval of aducanumab treatment for Alzheimer’s Disease
AMYVID FOR ALZHEIMER’S DIAGNOSIS In 2012, the FDA approved Amyvid (florbetapir F 18), a radiopharmaceutical for use in PET imaging of the brain to determine the presence of beta-amyloid plaque...
Continue reading CMS approval expected for Amyvid after FDA approval of aducanumab treatment for Alzheimer’s Disease